Kobayashi Pharmaceutical Co., Ltd. (KOY)
Munich
40.80
0.00 (0.00%)
Real-time Data
06:00 AM
Day's Range
40.8040.80
52 wk Range
27.6040.80
Financial Statements - KOY - Kobayashi Pharmaceutical Co., Ltd.
Revenue
165.74B▲ 0.1%
Net Income
3.66B▼ 63.7%Net Margin 2.2%
EBITDA
25.84B▼ 26.3%
Free Cash Flow
11.57B▲ 175.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 165.74B | 165.60B | 173.45B | 166.25B | 155.25B | 150.51B |
| Cost of Goods | 81.03B | 77.99B | 77.07B | 73.92B | 66.47B | 65.24B |
| Gross Profit | 84.71B | 87.60B | 96.37B | 92.33B | 88.77B | 85.26B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 14.92B | 24.86B | 25.78B | 26.67B | 26.07B | 25.94B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 3.74B | 13.91B | 27.55B | 27.95B | 27.63B | 26.63B |
| Income Tax | 83M | 3.84B | 7.22B | 7.92B | 7.92B | 7.43B |
| Net Income | 3.66B | 10.07B | 20.33B | 20.02B | 19.71B | 19.20B |
| EPS Basic | 49.19 | 135.42 | 268.16 | 259.63 | 252.36 | 245.71 |
| EPS Diluted | 49.19 | 135.42 | 268.16 | 259.59 | 252.36 | 245.71 |
| Basic Shares Outstanding | 74.33M | 74.33M | 12.30B | 12.17B | 12.33B | 12.34B |
| Diluted Shares Outstanding | 74.33M | 74.33M | 12.30B | 12.17B | 12.33B | 12.34B |
| Ebit | 3.77B | 13.94B | 27.58B | 27.96B | 27.65B | 26.65B |
| Ebitda | 25.84B | 35.06B | 33.56B | 33.81B | 32.98B | 31.98B |
| Net Income Continuous Operations | 3.74B | 13.91B | 27.55B | 27.95B | 27.63B | 26.63B |
| Minority Interests | -4M | -4M | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
